Institute of Human Reproduction says it conducted the NE’s first successful IVF delivery following ovarian rejuvenation using bone marrow-derived stem cells on June 15. (Photo Courtesy: IHR)
Guwahati, July 24 (MExN): The Institute of Human Reproduction (IHR), Guwahati is marking the World Embryology Day 2025 with two significant milestones - 30 years since the birth of North East India’s first IVF baby and the region’s first successful IVF delivery following ovarian rejuvenation using bone marrow-derived stem cells.
World Embryology Day, observed globally on July 25, commemorates the birth of the world’s first In Vitro Fertilisation (IVF) baby, Louise Brown, in 1978, and highlights the role of embryologists in fertility care.
According to a press release from IHR, the institute achieved a regional first milestone on July 7, 1995 and procedure was conducted under late Dr ML Goenka, at a time when assisted reproductive technology (ART) was still emerging in India.
Building on that foundation, the institute reported another landmark on June 15, 2025 with the birth of a baby girl conceived through IVF after undergoing ovarian rejuvenation, it said.
The patient had been diagnosed with diminished ovarian reserve and classified as a poor responder and underwent stem cell therapy using bone marrow-derived cells in July 2023, it added.
The IVF procedure and birth were carried out under the supervision of Dr ML Goenka and supported by a team comprising Dr Deepak Goenka, Dr Kanchan Murarka, Dr Abhimanyu Kalita, Dr Shamantaka Somyaji, and Dr Anil Agrawal, the release stated.
Speaking on the occasion, IHR Director Dr Deepak said the institute’s recent advances were part of its continued efforts to expand access to effective fertility care and assured its commitment to provide g hope to couples “facing infertility, through both established and emerging technologies.”
The institute also acknowledged the contributions of its Embryology Department, led by Rashmi Goenka, for its role in ensuring precision and care in fertility procedures.
IHR will continue to focus on research-driven clinical practice to address the evolving challenges in reproductive medicine, it added.
